Scan beyond Calumet and line up other specialty and renewables focused plays that could be setting up for the next move with the 19 high quality undiscovered gems.
To own Calumet, you need to be comfortable that the shift toward renewable fuels and specialty products can offset an unprofitable base business and a leveraged balance sheet. In the short term, the story still leans on Montana Renewables running reliably and on regulatory support remaining intact. Recent stock volatility does not change that underlying operational focus.
The biggest near term swing factor is execution on MaxSAF 150 and existing renewable diesel output, which ties directly into cash generation and any room to reduce debt. The main risk is that regulatory support or industry pricing weakens, which would pressure margins and leave that leverage harder to manage.
The MaxSAF 150 sustainable aviation fuel project remains the most important recent development for this Calumet story. Management plans for first half 2026 startup and capacity of 120 million to 150 million gallons a year. That potential volume gives the business a clearer pathway to scale within a regulated, credit heavy segment.
For catalysts, this project sits at the center of most expectations for higher quality revenue and stronger EBITDA margins once it is running. The flip side is execution risk. Any delay, cost overrun, or weaker than expected SAF economics would ripple across cash flow, debt reduction plans, and the broader investment narrative.
Calumet's narrative projects US$5.5b revenue and US$549.6m earnings by 2029. This assumes 6.0% yearly revenue growth and an earnings improvement of about US$686m from a loss of US$136.8m today.
Uncover why Calumet's fair value indicates a 28% potential upside to its current price, which could narrow quickly.
Some of the most optimistic analysts frame MaxSAF as the real swing factor for Calumet, arguing that a successful shift toward roughly 200 million gallons of SAF capacity could justify revenue climbing toward US$6.0b and earnings of about US$503.5m by 2029. Those forecasts were set before this news, so opinions may change as fresh information emerges. Use the range of views as a prompt to explore several competing narratives yourself.
Explore 2 other Calumet fair value estimates, including one that suggests as much as 1508% upside from the current price!
Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.
If the Calumet story has you thinking about portfolio gaps, it can help to line up a few focused stock lists and see how other businesses stack up on quality, income, or balance sheet strength.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com